强生医疗科技公司(Johnson & Johnson MedTech)是骨科技术领域的领导者,近日宣布与非阿片类疼痛治疗领域的领军企业Pacira生物科学公司达成战略合作协议。根据协议,强生将把用于治疗膝关节骨性关节炎疼痛的长效注射剂ZILRETTA?纳入其早期干预产品组合。协议还包括支持非手术治疗选择认知的教育计划。骨关节炎影响着美国超过3000万成年人,其中膝关节骨性关节炎是最常见的类型之一,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.